In the context of EMT, TGF-b1 treatment in gastric cancer cells promotes the expression of JARID1A demethylase, which is recruited by p-SMAD3 to CDH1 promoter, leading to gene silencing and promoting malignancy (Liang et al., 2015). The gene discussed is CDH1; the disease is gastric cancer.